At Taproot Medical Technologies, we’re solving some of the most urgent challenges in healthcare with our groundbreaking polymer biomaterial platform. We are developing several patient-focused products including a state-of-the-art ventricular shunt, which promises to dramatically improve the lives of children with hydrocephalus, and a novel hydrogel-based cell culture platform designed to eliminate key process bottlenecks and promote more widespread adoption of curative cell-based therapies for cancer patients. Taproot is bringing these life-changing products and more to the clinic through thoughtful application of our uniquely biocompatible polymers, hydrogels, and device coatings.
Taproot headquarters is located in the medical- and bio-technology hub of Bothell, just north of Seattle. Over the past several years, we have compiled a strong and growing patent portfolio, secured both private and government funding, and developed deep ties with world-renowned collaborators.